BGLAP and chronic kidney disease: In our previous works, in the adenine-induced chronic renal failure (CRF) mice vascular calcification (VC) model and the β-glycerophosphate (β-GP)-induced vascular smooth muscle cells (VSMC) calcification model, LJP61A was found to significantly inhibit VC phenotypes.